Filing Details
- Accession Number:
- 0001493152-22-007931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-28 20:00:15
- Reporting Period:
- 2022-03-25
- Accepted Time:
- 2022-03-28 20:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1642380 | Oncocyte Corp | OCX | In Vitro & In Vivo Diagnostic Substances (2835) | 271041563 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1808413 | T. Douglas Ross | C/O Oncocyte Corporation 15 Cushing Irvine CA 92618 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2022-03-25 | 15,000 | $1.40 | 20,317 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
